Sector Chart Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
14:26:17 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 11.18 USD | -2.40% |
|
+2.93% | +37.96% |
| 08-13 | Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating | MT |
| 08-07 | Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 222M | - | - | - | - | - |
| 69.02B | |||||
| 66.32B | |||||
| 27.66B | - | ||||
| 25.84B | - | ||||
| 26.54B |
Select your edition
All financial news and data tailored to specific country editions
